Shukui Qin
0000-0003-2289-1521
Publication & Citation Trends
Publications
0 total
胆道系腫瘍免疫療法の進展【JST・京大機械翻訳】
Cited by 0
Semantic Scholar
Mechanisms of bevacizumab inducing proteinuria in mice models
Cited by 0
Semantic Scholar
AFP陽性胃癌におけるC-MET,VEGF,EGFRおよびHER-2の発現を研究した。【JST・京大機械翻訳】
Cited by 0
Semantic Scholar
貝伐珠単抗はマウスの蛋白尿の形成機構を誘導する。【JST・京大機械翻訳】
Cited by 0
Semantic Scholar
P-0105ORAL C-MET INHIBITOR MSC2156119J AS MONOTHERAPY VERSUS SORAFENIB IN FIRST-LINE TREATMENT OF ASIAN PATIENTS WITH MET-POSITIVE ADVANCED HEPATOCELLULAR CARCINOMA AND CHILD-PUGH CLASS A LIVER FUNCTION: PHASE IB/II, MULTICENTER, RANDOMIZED TRIAL
Cited by 0
Semantic Scholar
Clinical Observation of GEMOX or GX as First Line Regimen for Advanced Billiary Tract Carcinoma
Cited by 0
Semantic Scholar
Endostar inhibits malignant ascites production in mice model bearing tumor ascites.
Cited by 0
Semantic Scholar
Mutation of k-ras mutation and evaluation of anti-EGFR monoclonal antibody combined with chemotherapy in Chinese colorectal cancer patients
Cited by 1
Semantic Scholar
Research Topics
Hepatocellular Carcinoma Treatment and Prognosis
(199)
Colorectal Cancer Treatments and Studies
(132)
Gastric Cancer Management and Outcomes
(109)
Lung Cancer Treatments and Mutations
(96)
Cancer Immunotherapy and Biomarkers
(71)
Affiliations
Shanxi Agricultural University
Nanjing University of Chinese Medicine
American Society of Clinical Oncology
Union Hospital
National Yang Ming Chiao Tung University